Liquidia Corp.
(NASDAQ : LQDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.83%37.200.9%$1872.43m
ABBVAbbVie, Inc. 0.69%104.921.9%$1090.76m
JNJJohnson & Johnson 0.12%143.850.7%$1078.54m
BMYBristol-Myers Squibb Co. 0.43%63.111.0%$715.33m
MRKMerck & Co., Inc. -0.10%79.980.7%$693.45m
LLYEli Lilly & Co. 1.53%146.961.1%$689.58m
AZNAstraZeneca Plc 0.05%52.631.2%$288.47m
GSKGlaxoSmithKline Plc -0.43%37.070.2%$233.58m
NVSNovartis AG 0.44%89.570.2%$180.22m
NVONovo Nordisk A/S 2.07%67.510.1%$96.43m
RGENRepligen Corp. 2.41%185.807.1%$94.95m
SNYSanofi 1.66%51.040.2%$76.52m
ARCTArcturus Therapeutics Holdings, Inc. 24.23%75.320.0%$71.61m
RPRXRoyalty Pharma Plc 2.27%41.900.2%$67.82m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.69%91.130.0%$67.68m

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.